法国前瞻性E3N-EPIC队列中自报风湿性多肌痛与巨细胞动脉炎诊断的准确性:一项验证研究
在纳入98,995名法国女性的E3N-EPIC前瞻性队列中,1,392人自报风湿性多肌痛(PMR)或巨细胞动脉炎(GCA),其中202人提供病历。经盲法病历复核,自报诊断准确率为87.6%;结合专项问卷和糖皮质激素报销数据库数据后,准确率提升至91.8%至92.8%。
要点
- E3N-EPIC队列中自报GCA/PMR诊断经病历复核准确率为87.6%。
- 结合专项问卷与糖皮质激素报销数据可将准确率提升至91.8%至92.8%。
- 队列中检出近600例GCA/PMR,可用于女性风险因素研究。
核心结论
- E3N队列中自报GCA/PMR诊断的准确性高,但使用专项GCA/PMR问卷和/或糖皮质激素报销数据库等额外数据可进一步提高准确性。
- 队列中检出近600例GCA/PMR病例,将能够研究女性GCA/PMR的风险因素。
研究设计与样本
- E3N-EPIC队列研究纳入98,995名1925年至1950年间出生的法国女性,于1990年招募,旨在研究癌症和慢性病的风险因素。
- 参与者每两年完成邮寄问卷以更新健康相关信息和生活方式特征;在三份问卷中,女性可自报GCA/PMR诊断。
- 对自报诊断的女性额外发送专项问卷以确认GCA/PMR自报诊断,并设计四种算法以提高识别准确性。
- 通过将诊断与盲法病历复核进行比较,计算自报诊断及每种算法的准确性。
主要发现
- 在98,995名参与者中,1,392名女性自报GCA/PMR;830名女性寄回专项问卷,202名女性提供病历。
- 对202份病历进行独立复核后,87.6%的自报GCA/PMR诊断准确。
- 使用专项问卷的额外数据(医生确诊和自报使用糖皮质激素超过3个月)和报销数据库数据(连续3个月内至少两次糖皮质激素发药)后,准确性提高至91.8%至92.8%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the accuracy of self-reported giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) diagnoses in a large French population-based prospective cohort, and to devise algorithms to improve their accuracy. METHODS: The E3N-EPIC cohort study (Etude Epidémiologique auprès des femmes de la Mutuelle Générale de l'Education Nationale) includes 98,995 French women born between 1925 and 1950, recruited in 1990 to study risk factors of cancer and chronic diseases. They completed biennially mailed questionnaires to update their health-related information and lifestyle characteristics. In three questionnaires, women could self-report a diagnosis of GCA/PMR. Those women were additionally sent a specific questionnaire, designed to ascertain self-reported diagnoses of GCA/PMR. Four algorithms were then devised to improve their identification. Accuracies of self-reported diagnoses and of each algorithm were calculated by comparing the diagnoses with a blinded medical chart review. RESULTS: Among 98,995 participants, 1,392 women self-reported GCA/PMR. 830 women sent back the specific questionnaire, and 202 women provided medical charts. After independent review of the 202 medical charts, 87.6 % of the self-reported diagnoses of GCA/PMR were accurate. Using additional data from a specific questionnaire (diagnosis confirmation by a physician, and self-report of >3-month of glucocorticoids), and from a reimbursement database (at least two deliveries of glucocorticoids in less than 3 consecutive months) improved their accuracy (91.8 % to 92.8 %). CONCLUSION: The accuracy of self-reported diagnosis of GCA/PMR was high in the E3N-cohort but using additional data as a specific GCA/PMR questionnaire and/or corticosteroid reimbursement database further improved this accuracy. With nearly 600 detected cases of GCA/PMR, we will be able to investigate risk factors for GCA/PMR in women.
引用
- Barde F, Ascione S, Pacoureau L, et al. Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study. Semin Arthritis Rheum. 2023. PMID: 38000317. doi:10.1016/j.semarthrit.2023.152298
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。